- Imatinib mesylate in Philadelphia chromosome-positive, chronic-phase …
Number of the records: 1  

Imatinib mesylate in Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon alpha

  1. TitleImatinib mesylate in Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon alpha / E. Tóthová ... [et al.]
    Another responsib. Tóthová, Elena (Author)
    Kafková, Adriana (Author)
    Fričová, Marta (Author)
    Beňová, Beáta (Author)
    Kirschnerová, G. (Author)
    Tóthová, Andrea (Author)
    Translated titleImatinib mesylát u Philadelfia pozitívneho chromozómu, v chronickej fáze myeloidnej leukémie po zlyhaní liečbou interferónom alfa
    Phys.des.Tab.
    NoteRes. angl.. Bibliogr. odkazy
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 52, no. 1 (2005), p. 63-67
    Call numberC 720
    MeSH Subject leukémia myeloidná chronická, BCR-ABL pozitívna - komplikácie - diagnostika - farmakoterapia
    farmakoterapia
    leukémia myeloidná chronická, BCR-ABL pozitívna
    interferón alfa - aplikácia a dávkovanie - použitie terapeutické
    cytogenetika
    aberácie chromozómové
    systematics616.155.392-085
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.